Trade Pfizer ^PFE

Pfizer (NYSE:PFE) Stock Price Down 1.7% - Here's What Happened

High Yield vs. Sustainable Growth: Why AbbVie's Dividend Beats Pfizer's Despite the Lower Payout - 24/7 Wall St.

Pfizer (NYSE:PFE) Shares Down 1.7% - Time to Sell? - Daily Political

Adaptive Biotechnologies (ADPT) Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals

Pharmaceutical Stocks To Watch Now - April 6th - Daily Political

Pfizer Inc. $PFE Shares Sold by Stratos Wealth Partners LTD.

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won't Pay a Dime | Investing.com

Quilter Plc Lowers Stock Holdings in Pfizer Inc. $PFE - Daily Political

Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and Pfizer (PFE) | Markets Insider

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial

Westwood Wealth Management Acquires Shares of 29,234 Pfizer Inc. $PFE - Daily Political

SS&H Financial Advisors Inc. Has $2.81 Million Holdings in Pfizer Inc. $PFE - Stock Observer

Poland, Romania Ordered to Honor Vaccine Deal with Pfizer

Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily

One U.S. College in Top 10 STEM Worldwide, Pfizer CEO Urges Structural Shift

Erste Group Remains a Hold on Pfizer (PFE) | Markets Insider

How Pfizer's Lyme Vaccine Trial Results Could Shape Pipeline Renewal for Pfizer (PFE) Investors

Pfizer Fails to Escape Warehouse Worker's Disability Bias Suit

38,600 Shares in Pfizer Inc. $PFE Acquired by Genesis Financial Group LLC

Pfizer Inc. $PFE Stock Position Reduced by First Pacific Financial

Aberdeen Group plc Sells 664,801 Shares of Pfizer Inc. $PFE

Hope as women get Sh650m boost for breast cancer care

Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer

Pharmaceutical Companies Pfizer, Johnson & Johnson Paid $12.6 Million in Bribes for Approvals, Contracts

Pfizer Site Closure Puts Cost Focus And R&D Productivity In Spotlight

Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology

Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments

Pfizer Site Closure Tests Cost Cuts And R&D Footprint Against Valuation - Simply Wall St News

Pfizer Inc. $PFE Shares Sold by HF Advisory Group LLC - Markets Daily

Best Pharmaceutical Stocks To Follow Now - April 2nd - Daily Political

Medulloblastoma Drugs Market Analysis and Growth Forecast 2026-2030 & 2035 by Drug Candidate, Product, Route of Administration, Distribution Channel, End-user and Region

Pfizer (PFE) Valuation Check After Recent Share Price Rebound And Mixed Growth Outlook

Pfizer Inc. $PFE Shares Purchased by Penn Davis Mcfarland Inc. - Stock Observer

J. Safra Sarasin Holding AG Buys Shares of 36,951 Pfizer Inc. $PFE - Stock Observer

Ambrosia slurps up a $100M series B for its oral obesity drug pipeline | BioWorld

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Pfizer (NYSE:PFE) Stock Price Up 1.7% - Still a Buy? - Markets Daily

Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Pfizer Wins €1.9 Billion Covid Vaccine Case With Poland, Romania

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pfizer Pulls Back From South San Francisco

Doxorubicin Market Outlook 2026-2030 & 2035: Predicted to Surge to $2 Billion by 2030, Bolstered by Expanding Access to Cancer Care

Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030

Pfizer (PFE) Valuation Check As Phase 3 Lyme Vaccine And Prostate Cancer Results Draw Focus

Meyer Handelman Co. Sells 50,802 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Bought by Capital Advisors Inc. OK

Vaughan Nelson Investment Management L.P. Reduces Holdings in Pfizer Inc. $PFE - Stock Observer

Shrier Wealth Management LLC Takes Position in Pfizer Inc. $PFE - Daily Political

Marksans Pharma gains on securing USFDA approval for Benzonatate Capsules

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2− locally-advanced or metastatic breast cancer

Pfizer (NYSE:PFE) Stock Price Up 1.1% - Here's What Happened - Markets Daily

Pharmaceutical Stocks To Watch Today - March 31st

Pfizer (NYSE:PFE) Trading Up 1.1% - What's Next? - Stock Observer

Here's Why You Don't Bet Against This Dividend King

Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 - Here's Why

Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry

Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players

Pfizer (NYSE:PFE) Hits New 52-Week High - Should You Buy? - Daily Political

Is It Time To Reconsider Pfizer (PFE) After Diverging Valuation Narratives?

Pfizer (NYSE:PFE) Shares Up 2.6% - Time to Buy?

Announced in June, positive topline results from registratio

Pfizer's (PFE) Shares Up Since Jim Cramer Said "Pass"

Eli Lilly's (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer

$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

Pfizer (PFE) - Among the 15 Large Cap Stocks with Highest Dividends

Prediction: Buying Pfizer Stock Today Could Set You Up for Life

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks: Top 5 Stocks

Pfizer (NYSE:PFE) Stock Price Down 2% - Here's What Happened

Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of "Hold" from Analysts

Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples

Pfizer Oncology Wins Raise Questions On Valuation Gap And Future Revenues

Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program

Top Pharmaceutical Stocks To Watch Today - March 25th - Markets Daily

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Exchange Traded Concepts LLC Sells 60,810 Shares of Pfizer Inc. $PFE - Stock Observer

Pfizer (NYSE:PFE) Trading Down 2% - Here's Why

Preliminary Results for the Year Ended 31 December 2025

Jim Cramer on Pfizer: "I Just Need to Know Their Product Flow Better"

Jim Cramer Broke Down 5 Stocks Including Pharma Plays for Rising Oil

Should Pfizer's (PFE) New Lyme Vaccine and Oncology Wins Reshape Its Post‑COVID Pipeline Story?

Is Pfizer's Late‑Stage Lyme Vaccine Progress Reshaping the Investment Case for PFE?

Pfizer Inc. $PFE Shares Acquired by Fort Washington Investment Advisors Inc. OH

Pfizer (NYSE:PFE) Price Target Raised to $36.00

Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data